Targeted next-generation sequencing-based mutational signature analysis in endometrial cancer: utility and limitations across molecular subtypes.

Published

Research record: Targeted next-generation sequencing-based mutational signature analysis in endometrial cancer: utility and limitations across molecular subtypes.

Published in J Pathol Transl Med; first publication date 2026-11-10. PMID 43040991.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Read the original publication on PubMed

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-11-10

Updated

2026-11-19

Disclaimer

professional use

Explorar más